Stockscreener 앱 받기
6.08
7.80%
0.44
시간 외 거래:
6.25
0.17
+2.80%
전일 마감가:
$5.64
열려 있는:
$5.67
하루 거래량:
798.85K
Relative Volume:
0.90
시가총액:
$531.01M
수익:
-
순이익/손실:
$-95.90M
주가수익비율:
-4.6061
EPS:
-1.32
순현금흐름:
$-79.09M
1주 성능:
+11.15%
1개월 성능:
+34.22%
6개월 성능:
+35.71%
1년 성능:
-10.85%
1일 변동 폭
$5.635
$6.1985
1주일 범위
$5.34
$6.34
52주 변동 폭
$1.865
$11.40
턴스 파마슈티컬스 Stock (TERN) Company Profile
명칭
Terns Pharmaceuticals Inc
전화
650-525-5535 EXT.101
주소
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
6.08 | 495.21M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
턴스 파마슈티컬스 Stock (TERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2024-10-31 | 개시 | Oppenheimer | Outperform |
| 2023-06-22 | 개시 | Mizuho | Buy |
| 2023-06-07 | 개시 | Jefferies | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-08 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-14 | 개시 | JMP Securities | Mkt Outperform |
| 2023-02-07 | 개시 | UBS | Buy |
| 2022-09-12 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-14 | 재개 | Goldman | Buy |
| 2021-03-02 | 개시 | Cowen | Outperform |
| 2021-03-02 | 개시 | Goldman | Buy |
| 2021-03-02 | 개시 | JP Morgan | Overweight |
모두보기
턴스 파마슈티컬스 주식(TERN)의 최신 뉴스
Terns Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks
Custom strategy builders for tracking Terns Pharmaceuticals Inc.Downside Control Plan With Support Analysis - Newser
Is Terns Pharmaceuticals Inc. stock bottoming outFree Wealth Building Stock Market Ideas - Newser
Best data tools to analyze Terns Pharmaceuticals Inc. stockVolume Based Swing Signal Prediction Map - Newser
William Blair Has Positive Outlook of TERN FY2025 Earnings - Defense World
Will earnings trigger a reversal in Terns Pharmaceuticals Inc.Low Exposure Strategy with Sector Analysis - Newser
Applying chart zones and confluence areas to Terns Pharmaceuticals Inc.AI Trend Detection for Entry Timing - Newser
What institutional flow reveals about Terns Pharmaceuticals Inc.Risk-Managed Strategy Based on Price Analysis - Newser
How Terns Pharmaceuticals Inc. stock performs during market volatilityFree Portfolio Diversification Stock Ideas - Newser
What makes Terns Pharmaceuticals Inc. stock price move sharplyAI-Based Stock Behavior Forecast Engine - Newser
Heatmap analysis for Terns Pharmaceuticals Inc. and competitorsAlgorithmic Prediction of Market Breakouts - Newser
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors - Benzinga
Terns Pharmaceuticals Beats Loss Projections And Ramps Up Drug Trials - Finimize
Terns Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Terns Pharmaceuticals: Earnings Beat and Strategic Pipeline Momentum Signal Long-Term Growth Potential - AInvest
Terns Pharma reports Q2 net loss - MarketScreener
Terns Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - The Manila Times
Terns Pharmaceuticals Inc. stock prediction for this weekFree Weekly Stock Opportunity Radar Scanner - Newser
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Biotech Terns Pharmaceuticals Appoints Chief People Officer, Awards Massive 500,000 Share Option Package - Stock Titan
Should I hold or sell Terns Pharmaceuticals Inc. stock in 2025Discover breakthrough stocks before the crowd - Jammu Links News
How strong is Terns Pharmaceuticals Inc. company’s balance sheetOutstanding capital growth - Jammu Links News
What is the risk reward ratio of investing in Terns Pharmaceuticals Inc. stockTurn volatility into profit opportunities - Jammu Links News
What drives Terns Pharmaceuticals Inc. stock priceAchieve consistent profits with expert advice - Jammu Links News
How does Terns Pharmaceuticals Inc. generate profit in a changing economyTake advantage of unprecedented market momentum - Jammu Links News
What analysts say about Terns Pharmaceuticals Inc. stockCapitalize on proven trading setups - Jammu Links News
What institutional investors are buying Terns Pharmaceuticals Inc. stockGain insights from top financial experts - Jammu Links News
Is Terns Pharmaceuticals Inc. stock overvalued or undervaluedHigh-yield capital appreciation - Jammu Links News
Terns Pharmaceuticals Inc. stock trend forecastMarket Correction Proof Stock Screening Analysis - newser.com
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
What are Terns Pharmaceuticals Inc. company’s key revenue driversSuperior stock growth - Jammu Links News
Terns Pharmaceuticals (TERN) to Release Quarterly Earnings on Monday - Defense World
Terns TERN 2025Q2 Earnings Preview Upside Potential with Improved EPS Forecast - AInvest
What catalysts could drive Terns Pharmaceuticals Inc. stock higher in 2025Wealth Building Planner With Proven Results - Jammu Links News
Terns Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowEarly Breakout Tracker - beatles.ru
턴스 파마슈티컬스 (TERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):